Donate For Public and Patients Store Search

F101 - Advanced Dermoscopy

Sunday, March 3; 3:30 PM - 5:30 PM

Learning Objectives

Following this course, the attendee should be able to:

  • Differentiate among pigmented skin lesions on specific body sites
  • Analyze the dermoscopic morphology of non-pigmented and spitzoid-looking tumors
  • Manage morphologically doubtful lesions efficiently, in order to minimize the risk of missing a malignant tumor

Description

This session will cover some of the most challenging topics in the field of skin cancer diagnosis. Participants will learn the dermoscopic morphology of pigmented lesions on specific sites and diagnostic strategies to differentiate among them. Special emphasis will also be given on the diagnostic approach for non-pigmented tumors and spitzoid-looking neoplasms and management rules will be introduced. All the presentations will include numerous cases from the clinical practice, facilitating the understanding of the suggested strategies and enhancing attendees to learn how to apply them.

Disclosures

  • Kittler, Harald, MD: Almirall – Speaker/Faculty Education(H); Fotofinder – I(EQ);
  • Lallas, Aimilios, MD, MSc, PhD: 3Gen, LLC – A(EQ); Amgen – I(Fees); Avène – Speaker/Faculty Education(H); Bioderma – SP(H); Elsevier Inc. – O(Fees); Fotofinder – A(EQ); Galderma Laboratories, L.P. – SP(H); La Roche-Posay Laboratorie Pharmaceutique – I(Residency/Fellowship Program Funding), Speaker/Faculty Education(H); LEO Laboratories Ltd (LEO Pharma) – A(H), I(Grants/Research Funding); Novartis – A(H);
  • Malvehy, Joseph, MD: Cedilp – F(S); Taylor & Francis – O(IP);
  • Pellacani, Giovanni, MD: Mavig – SP(H);
  • Puig, Susana, MD: Almirall – A(H), SP(Fees); Amgen – A(H); Avène – C(H); Bristol-Myers Squibb – A(H), I(Fees); Canfield Scientific, Inc. – C(H); Cantabria – O(Grants/Research Funding); Diagnosis Dermatologica – B(H); GlaxoSmithKline – A(H), I(Fees); ISDIN – O(Grants/Research Funding), SP(H); La Roche-Posay Laboratorie Pharmaceutique – O(Grants/Research Funding), SP(H); La Roche-Posay Laboratoire Pharmaceutique – A(H); Leo Pharma Inc – A(Fees), SP(H); Lucid, Inc. – I(EQ); Novartis – O(Grants/Research Funding), Speaker/Faculty Education(Fees); Roche Laboratories – A(H), O(Fees); Sanofi/Regeneron – Speaker/Faculty Education(Fees); Taylor & Francis – O(IP);
  • Soyer, H. Peter, MD: Canfield Scientific, Inc. – C(Fees); e-derm-consult GmbH – F(NC); Fotofinder – I(Grants/Research Funding); iDoc24 – A(NC); Molemap Australia – A(Fees), C(ST);
Schedule
Sunday, March 3
3:30 PM
Dr. Lallas / Pigmented facial lesions
3:50 PM
Dr. Kittler / Pigmented acral and nail lesions
4:10 PM
Dr. Puig / Pigmented mucosal lesions
4:30 PM
Dr. Soyer / Non pigmented macules
4:50 PM
Dr. Malvehy / Non pigmented nodules
5:10 PM
Dr. Pellacani / Spitzoid-looking lesions
Event Details
  • Date
    Sunday, March 3
  • Time
    3:30 PM - 5:30 PM
  • Location
    Room 202A
  • CME Credits
    2.00
  • Type
Directors/Co-Directors
  • Aimilios Lallas, MD, MSc, PhD - Handout
Speakers
  • Giovanni Pellacani, MD
  • H. Peter Soyer, MD
  • Harald Kittler, MD
  • Joseph Malvehy, MD
  • Susana Puig, MD